21256 ⎘
Medicinal preparations containing active ingredients not provided for in groups - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
POLYMERIC MICROPARTICLES FOR THE LOCAL TREATMENT OF CHRONIC INFLAMMATORY DISEASES
#5102INHALABLE DRY POWDER FORMULATIONS COMPRISING ANGIOGENESIS INHIBITORS
#5103Mycophenolate oral suspension
#5104DRUG DELIVERY FOR INTERVERTEBRAL DISC PAIN MANAGEMENT
#5105INFANT FORMULA
#5106PROTEIN SEQUENCING METHOD AND REAGENTS
#5107METHODS FOR DETECTING AND PREDICTING CANCER AND/OR CIN3
#5108METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE AND ENZYME USED FOR THE SAME
#5109Methods of Treating Muscular Dystrophy
#5110TREATMENT OF TUMORS WITH MIRNA TARGETING CDK4/CDK6
#5111COMBINATION THERAPY WITH AN ANTI-CA19-9 ANTIBODY AND FOLFIRINOX IN THE TREATMENT OF CANCER
#5112ANTI-CEA ANTIBODIES AND METHODS OF USE
#5113ANTI-ACVR1 ANTIBODIES AND USES THEREOF
#5114ANTI-FGFR2 ANTIBODIES AND METHODS OF USE THEREOF
#5115Anti-Axl Antagonistic Antibodies
#5116COMBINATION OF ANTI-GARP ANTIBODY AND IMMUNOMODULATOR
#5117ANTIBODY FOR BINDING TO INTERLEUKIN 4 RECEPTOR
#5118METHOD OF TREATING DISEASES USING GREMLIN1 ANTAGONISTS
#5119NKG2D-IG FUSION PROTEIN FOR CANCER IMMUNOTHERAPY
#5120HUMAN INSULIN C-ALPHA-PEPTIDES AND METHODS OF USE
#5121ENGINEERED INTERLEUKIN-10 AND FUSION PROTEINS THEREOF
#5122NEMO COILED COIL MIMICS AND METHODS OF USING SAME
#5123PEPTIDE PLATINUM COMPLEXES AND METHODS OF USE THEREOF
#5124PLASMA KALLIKREIN INHIBITORS
#5125ANTIVIRAL PRODRUGS OF ETV AND FORMULATIONS THEREOF
#5126Bruton's Tyrosine Kinase (BTK) INHIBITOR AND APPLICATION THEREOF
#5127EPOXYAMIDES AS KRAS G12C AND KRAS G12D INHIBITORS AND METHODS OF USING THE SAME
#5128MODULATORS OF BCL6 PROTEOLYSIS AND ASSOCIATED METHODS OF USE
#5129CARBAZOLE-CONTAINING AMIDES, CARBAMATES, AND UREAS AS CRYPTOCHROME MODULATORS
#5130THERAPEUTIC AMINOINDANE COMPOUNDS AND COMPOSITIONS
#5131LIPID NANOPARTICLE COMPOSITIONS FOR DELIVERING CIRCULAR POLYNUCLEOTIDES
#5132METHODS FOR TREATING GLIOBLASTOMA OR RECURRENT GLIOBLASTOMA UTILIZING A WIRELESS SIGNAL ALONE OR IN COMBINATION WITH ONE OR MORE CANCER DRUGS, AND ASSOCIATED SYSTEMS, APPARATUSES, AND DEVICES
#5133METHODS FOR TREATING CANCERS
#5134Targeted Therapeutic Lipid Nanoparticles and Methods of Use
#5135ANTIBODIES TO PMEL17 AND CONJUGATES THEREOF
#5136ENGINEERED NATURAL LIGAND-BASED CAR: DIRECTED EVOLUTION OF THE STRESS-RECEPTOR NKP30
#5137NATURAL KILLER T CELL LIGAND LOADED EXTRACELLULAR NANOVESICLE AND AUTOLOGOUS ANTI-CANCER VACCINE FOR HEMATOLOGIC MALIGNANCIES COMPRISING THE SAME
#5138COMPOUNDS FOR USE IN INDUCING MYOCARDIAL PERFUSION RECOVERY
#5139COMPOSITIONS AND METHODS FOR TREATING SPINAL MUSCULAR ATROPHY
#5140BACTERIOPHAGE COMPOSITIONS FOR TREATING STAPHYLOCOCCUS INFECTION
#5141COMPOSITIONS FOR PROTECTION AGAINST PATHOGEN INFECTION AND METHOD THEREOF
#5142BIOEFFECTIVE KRILL OIL COMPOSITIONS
#5143CAR-T CELLS TARGETING UPAR AND USES THEREOF
#5144CHIMERIC ANTIGEN RECEPTORS TO TARGET CD5-POSITIVE CANCERS
#5145IL-13RA2 CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE
#5146METHODS FOR RAISING NITRIC OXIDE AND REDUCTION OF URIC ACID
#5147LIPID NANOPARTICLE COMPOSITIONS FOR DELIVERING CIRCULAR POLYNUCLEOTIDES
#5148MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes
#5149NUCLEOSIDE DERIVATIVES AND METHODS OF USE THEREOF
#5150USE OF 6-THIO-dG TO TREAT THERAPY-RESISTANT TELOMERASEPOSITIVE PEDIATRIC BRAIN TUMORS
#5151Cyclic Pyridine Derivatives as cGAS Inhibitors
#5152SOLID DISPERSIONS
#5153COMPOSITION FOR TREATING ACUTE BRAIN INJURY OR NEURODEGENERATIVE DISEASE, METHOD OF MAKING, AND USE THEREOF
#5154METHODS AND COMPOSITIONS FOR MAINTAINING OPIOID EFFICACY IN THE TREATMENT OF PAIN
#5155CONTROLLED-RELEASE NICOTINE CHEWING GUM
#5156NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ANOREXIA NERVOSA AND BINGE EATING DISORDER
#5157Compositions And Methods For Treating Gulf War Illness
#5158Autotaxin inhibitor compounds
#5159Lactoyl Amino Acids for the Treatment of Metabolic Disease
#5160CONDUCTIVE STIMULI-RESPONSIVE COLLOIDAL MICROGELS AND THEIR FILM HOMOLOGUES: SYNTHESIS USING CATECHOL GROUPS AS CROSSLINKING AND DOPING AGENTS, AND MECHANO-ELECTRICAL PROPERTIES
#5161CYCLOSPORINE COMPOSITIONS AND METHODS OF USE THEREOF
#5162PROCESS FOR CONTINUOUS HOT MELT GRANULATION OF LOW SOLUBLE PHARMACEUTICALS
#5163COMPOSITIONS COMPRISING PROPIONIBACTERIUM ACNES BACTERIOPHAGES FOR TREATING ACNE
#5164METHODS OF ENHANCING ANTIBODY THERAPIES
#5165Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS
#5166ANTI-CNTN4 ANTIBODY AND USE THEREOF
#5167IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING LUNG CANCER
#5168TOLL-LIKE RECEPTOR ANTAGONIST COMPOUNDS AND METHODS OF USE
#5169Diacylglycerol kinase modulating compounds
#5170METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH HYPERMINERALIZATION
#5171COMPOUNDS USEFUL IN HIV THERAPY
#5172COMPOUNDS FOR THE ACTIVATION OF AMPK
#5173Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
#5174PEGYLATED T CELL ENGAGER WITH DUAL SPECIFICITIES TO CD3 AND CD19
#5175Compositions and Methods for Treating Biofilm-Related Lung Conditions
#5176SYNTHETIC INTERMEMBRANE PROTEOLYSIS RECEPTORS FOR CUSTOM ANTIGEN-INDUCED TRANSCRIPTIONAL REGULATION
#5177AMURINS LYSINS, AND LYSIN-ANTIMICROBIAL PEPTIDE (AMP) CONSTRUCTS ACTIVE AGAINST GRAM-NEGATIVE BACTERIA
#5178TREATMENT OF HYPOPARATHYROIDISM
#5179LGG-DERIVED PEPTIDES AND METHODS OF USE THEREOF
#5180BRUISING AND FILLER COMPOSITIONS AND METHODS FOR USE
#5181METHODS FOR DETERMINING TUMOR IMMUNE STATUS
#5182ADENOVIRUS ENCODING IL-15
#5183DIAGNOSIS AND TREATMENT OF MYELOID DISORDERS AND ACUTE LEUKEMIAS USING NOVEL TUMOR SPECIFIC ANTIGENS
#5184FIBER SUPPLEMENTATION PROTECTS FROM ANTIBIOTIC-INDUCED GUT MICROBIOME DYSBIOSIS BY MODULATING REDOX METABOLISM
#5185STAUFEN1 AGENTS AND ASSOCIATED METHODS
#5186Combination therapy for HIV with adenosine derivative and capsid inhibitors
#5187COMPOSITIONS COMPRISING TOPIRAMATE FOR TREATING DERMATOLOGICAL CONDITIONS
#5188Azithromycin and roxithromycin derivtives as senolytic drugs
#5189Use of baicalin in preparation of drug for treating tumor irresponsive to immune checkpoint inhibitors (ICIs)/undergoing hyperprogression
#5190ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE
#5191IMMUNOMODULATORY OLIGOSACCHARIDES FOR THE ENHANCEMENT OF ANTI-TUMOR EFFICACY OF IMMUNO-ONCOLOGY AGENTS
#5192TREATMENT OF INFECTIOUS DISEASES USING BCL-2 FAMILY PROTEIN INHIBITORS
#5193METHODS OF TREATING DISORDERS WITH ULK INHIBITORS
#5194EZH2 INHIBITORS FOR TREATING CANCER
#5195Use of pyrrolopyridine derivatives for preventing or treating inflammatory diseases
#5196THE THERAPEUTIC REGIMEN
#5197Combination of Talazoparib and an Anti-Androgen for the Treatment of DDR Gene Mutated Metastatic Castration-Sensitive Prostate Cancer
#5198USES OF FATTY ACID AMIDE HYDROLASE INHIBITORS IN TREATMENT OF TRAUMA RELATED PSYCHIATRIC DISORDERS
#5199Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor
#5200METHOD OF INCREASING BIOAVAILABILITY AND/OR PROLONGING OPHTHALMIC ACTION OF A DRUG
#5201BENZAMIDE COMPOUNDS
#5202USE OF PPAR(gamma) AGONISTS OR MPC INHIBITORS FOR TREATING PRIMARY, INNATE DISEASES OF THE CARDIAC MUSCLE (CARDIOMYOPATHIES)
#5203AMIDE DERIVATIVES OF BUTYRIC ACID FOR USE IN THE TREATMENT OR PREVENTION OF SARS-COV-2 INFECTION
#5204METHODS AND COMPOUNDS OF CANNABIDIOL, MELATONIN AND AKBA FOR TREATING PANCREATIC CANCER
#5205COMPOSITIONS AND METHODS FOR IMMUNE-MEDIATED INFLAMMATORY DISEASES
#5206USE OF BETA-ADRENERGIC INVERSE AGONISTS FOR SMOKING CESSATION
#5207IMMUNOFUNCTIONAL CARRIER, METHODS OF USES, AND COMPOSITION MATTERS AS AN ANTITUMOR IMMUNOTHERAPY
#5208Method for Treating Inflammatory Skin Conditions and other Topical Conditions or Disorders
#5209Sterically stabilized carrier compositions for treating a mammal
#5210METHODS FOR TREATING CANCERS BY USING NANOFRAMES OF PRUSSIAN BLUE OR AN ANALOGUE THEREOF AND ITS PRODUCTION METHODS
#5211Treatment of Parkinson's Disease
#5212Antimicrobial Compositions and Related Methods of Use
#5213COMPOSITIONS AND METHODS FOR MONITORING ENPP1 ACTIVITY
#5214OPTICAL TRANSMISSION SAMPLE HOLDER AND ANALYSIS, PARTICULARLY FOR HEMOGLOBIN
#5215THERAPEUTIC AND DIAGNOSTIC METHODS FOR MAST CELL-MEDIATED INFLAMMATORY DISEASES
#5216PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND/OR TREATMENT OF INFECTIONS AND ANTIBACTERIAL-INDUCED DYSFUNCTIONS
#5217ANTI-C5 ANTIBODY/C5 IRNA CO-FORMULATIONS AND COMBINATION THERAPIES
#5218RUNX1 Inhibition for Treatment of Proliferative Vitreoretinopathy and Conditions Associated with Epithelial to Mesenchymal Transition
#5219OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF
#5220METHODS FOR TREATING GYNECOLOGIC CANCER USING COMBINATION THERAPY WITH ANTI-MUC16 x CD3 MULTISPECIFIC ANTIBODIES AND VEGF INHIBITORS
#5221PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) ANTIBODIES, CONJUGATES, COMPOSITIONS, AND USES THEREOF
#5222ANTI-KLRG1 ANTIBODIES
#5223ANTI-CD47 ANTIBODIES AND USES THEREOF
#5224HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE
#5225RYANODINE RECEPTOR INHIBITOR COMPOUNDS AND METHODS RELATING THERETO
#5226SOLID FORMS OF A COMPOUND FOR MODULATING COT
#5227Spirocycle Containing Bicyclic Heteroaryl Compounds
#5228MAP4K1 INHIBITORS
#5229Pyrazolopyrimidine compounds as kinase Inhibitors
#5230Spirocycle Containing Pyridine Compounds
#5231Spirocycle Containing Pyridone Compounds
#5232COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR
#5233Compounds and methods for CD73 modulation and indications therefor
#5234HETEROARYL DERIVATIVES AS APELIN RECEPTOR AGONISTS
#5235SELECTIVE HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF HUMAN DISEASE
#5236METHODS FOR POTENTIATING ANTIMICROBIAL AGENTS
#5237METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY
#5238CYCLIC PEPTIDYL INHIBITORS OF CAL-PDZ BINDING DOMAIN
#5239CYCLIC DINUCLEOTIDE CONJUGATES AND RELATED METHODS OF USE THEREOF
#5240LUTEINIZING HORMONE-RELEASING HORMONE RECEPTOR (LHRH-R) CONJUGATES AND USES THEREOF
#5241Pharmaceutical compositions comprising meloxicam
#5242THERAPEUTIC COMBINATION FOR TREATING CANCER
#5243Compositions and Methods For Reducing Immune Intolerance
#5244Methods to Improve the Therapeutic Index of Activated T Cells
#5245RETRO - INVERSO REGULATORY T CELL EPITOPES
#5246PSEUDOMONAS BACTERIOPHAGE AND USES THEREOF
#5247Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome
#5248AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE UROGENITAL SYSTEM
#5249PHARMACEUTICAL COMPOSITIONS COMPRISING SUBSTITUTED NUCLEOTIDE AND NUCLEOSIDE FOR TREATING VIRAL INFECTIONS
#5250METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA
#5251BENZODIAZEPINES FOR TREATING OR PREVENTING RESPIRATORY SYNCYTIAL VIRUS INFECTION
#5252NASAL COMPOSITIONS COMPRISING ALCAFTADINE
#5253NEW TREATMENT
#5254ANTIVIRAL JAK INHIBITORS USEFUL IN TREATING OR PREVENTING RETROVIRAL AND OTHER VIRAL INFECTIONS
#5255METHODS OF USING EHMT2 INHIBITORS IN IMMUNOTHERAPIES
#5256DRY EYE TREATMENTS
#5257TREATMENT OF SICKLE CELL ANAEMIA
#5258Pharmaceutical Composition Comprising a Benzoheterocyclic Compound and Androgen Receptor Pathway Modulator and Application Thereof
#5259SYSTEM, METHOD, AND TREATMENT FOR THE OVERDOSE OF XYLAZINE CONTAINING SUBSTANCES
#5260MODULATORS OF THE INTEGRATED STRESS PATHWAY
#5261RAPAMYCIN ANALOGS AND USES THEREOF
#5262NOVEL USE
#5263METHODS AND COMPOSITIONS FOR INHIBITING FORMATION OF THE HIV LATENT RESERVOIR
#5264MIRDAMETINIB TREATMENT
#5265EXTRACELLULAR VESICLES FROM MICROALGAE, THEIR PREPARATION, AND USES
#5266Topical Testosterone (T) for Promoting Hair Growth-Containing Formulations
#5267NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES
#5268NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES
#5269PREDICTING THERAPEUTIC RESPONSE
#5270METHODS FOR PREDICTING TREATMENT OUTCOME TO CHECKPOINT INHIBITORS IN CANCER
#5271Methods for Treatment of Alport Syndrome
#5272METHODS OF TREATING OSMIDROSIS
#5273TEMPLATE DIRECTED IMMUNOMODULATION FOR CANCER THERAPY
#5274IMMUNOGENIC ARGINASE PEPTIDES
#5275Anti-A2AP antibodies and uses thereof
#5276INFLAMMATORY DISEASE TREATMENT USING ANTI-TISSUE FACTOR ANTIBODIES
#5277HER2/4-1BB BISPECIFIC FUSION PROTEINS FOR THE TREATMENT OF CANCER
#5278COMBINATION THERAPIES FOR TREATMENT OF BCMA-RELATED CANCERS AND AUTOIMMUNE DISORDERS
#5279CHIMERIC ANTIGEN RECEPTORS TARGETING CANCER
#5280NON-PLATELET DEPLETING AND NON-RED BLOOD CELL DEPLETING CD47 ANTIBODIES AND METHODS OF USE THEREOF
#5281METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND TIGIT INHIBITORS
#5282ANTI-LAG3 ANTIBODIES AND USES THEREOF
#5283Anti-GDF-15 antibodies
#5284A-FABP NEUTRALIZING MONOCLONAL ANTIBODY AND PREPARATION METHOD AND USE THEREOF
#5285MONOCLONAL ANTIBODY AND USES THEREOF FOR THE TREATMENT AND DIAGNOSIS OF MULTIDRUG-RESISTANT PATHOGENIC BACTERIAL INFECTIONS
#5286PEPTIDIC POSITIVE ALLOSTERIC MODULATORS TARGETING TRPV1
#5287NOVEL USE OF PEPTIDE FOR INHIBITING FUNCTIONS AND EXPRESSIONS OF MULTIPLE DISEASE BIOMARKERS
#5288HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS
#5289IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AND THEIR USE IN THERAPY
#5290POTENT AND SELECTIVE COMPOUNDS AS SEROTONIN 1B RECEPTOR MODULATORS
#5291COMPOUNDS AND METHODS FOR TREATING MALARIA
#5292INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#5293NON-POLYAMINE BASED POLYAMINE TRANSPORT INHIBITORS AND THEIR USE IN THE TREATMENT OF HUMAN CANCERS
#5294PROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR) COMPOUNDS AND METHODS OF USING THE SAME
#5295MULTI-TARGETED TYROSINE KINASE INHIBITORS AND THEIR PHARMACEUTICAL USES
#5296INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#5297COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THE SAME
#5298GRANZYME B DIRECTED IMAGING AND THERAPY
#5299MODIFIED SELF-IMMOLATING MOIETIES FOR USE IN PRODRUGS AND CONJUGATES AND METHODS OF USING AND MAKING
#5300PRO-CYCLIC DINUCLEOTIDES AND PRO-CYCLIC DINUCLEOTIDE CONJUGATES FOR CYTOKINE INDUCTION
#5301Vaginal Hydrogel
#5302COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS
#5303Methods and Compositions for Treating Cancers by Inhibiting Estrogen Signaling in Myeloid-Derived Suppressor Cells
#5304Sequence specific antimicrobials
#5305USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
#5306METHODS AND MATERIALS FOR TARGETING TUMOR ANTIGENS
#53074'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO
#5308GALACTOPYRANOSYL-CYCLOHEXYL DERIVATIVES AS E-SELECTIN ANTAGONISTS
#5309COMPOSITIONS AND METHODS FOR TREATING BLADDER CONDITIONS
#5310NITRIC OXIDE-SENSITIVE HYDROGEL
#5311Compounds, Compositions and Methods of Treating or Preventing Acute Lung Injury
#5312ORGANIC COMPOUNDS
#5313METHODS FOR THE TREATMENT AND PREVENTION OF DISEASES OR INFECTIONS WITH MCP-1 INVOLVEMENT BY ADMINISTRATION OF TAFENOQUINE
#5314METHODS AND COMPOSITIONS FOR TREATING MELANOMA
#5315NOVEL SALTS OF SELECTIVE ESTROGEN RECEPTOR DEGRADERS
#5316Ascorbic acid and quinone compounds in combination with an antiparasitic agent for treating a parasitic disease
#5317THERAPEUTIC TARGETING OF RECEPTOR TYROSINE KINASE INHIBITOR-INDUCED ANDROGEN RECEPTOR PHOSPHORYLATION IN CANCER
#5318PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF MELANOMA
#5319Isoflavonoid compositions and methods for the treatment of cancer
#5320GLUTAMINASE INHIBITOR THERAPY
#5321ANTIVIRAL THERAPEUTIC COMPOUNDS AND COMPOSITIONS FOR USE IN TREATMENT OF CORONAVIRUS AND INFLUENZA VIRUS
#5322METHODS FOR TREATING NEUROBLASTOMA
#5323Use of atovaquone and proguanil for treatment of gastrointestinal diseases and inflammation
#5324USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#5325COMPOSITIONS FOR THE TREATMENT OF A DISEASE OF THE URINARY TRACT AND TREATMENT OF A DISEASE INVOLVING THE INTRACELLULAR DELIVERY OF THE PARTICLE OR A MEDICAMENT CONTAINED THEREIN
#5326DRUG DELIVERY SYSTEM
#5327Pharmaceutical Formulation
#5328Precision Medicine Approach to Targeting Neurodegeneration
#5329PROTEOGENOMIC ANALYSIS OF NON-SMALL CELL LUNG CANCER
#5330COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF ALT CANCER
#5331MRNA TREATMENT NANOPARTICLES
#5332NUCLEIC ACIDS SIMULTANEOUSLY INHIBITING EXPRESSION OF C-MET GENE AND PD-L1 GENE
#5333METHODS AND COMPOSITIONS USED TO MODIFY CHROMATIN ARCHITECTURE TO REGULATE PHENOTYPE IN AGING AND CANCER
#5334ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF
#5335ANTI-HUMAN CXCR5 ANTIBODY AND USES THEREOF
#5336VISTA Antagonist and Methods of Use
#5337BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND LEPTIN RECEPTOR AND/OR GP130, AND METHODS OF USE THEREOF
#5338MULTIFUNCTIONAL BTLA EXTRACELLULAR DOMAIN CO-INHIBITORY MOIETY TRAPS TO MODULATE IMMUNE TOLERANCE
#5339Antibody Agents Directed Against Lymphocyte Activation Gene-3 (LAG-3) and Uses Thereof
#5340METHODS FOR TREATING CHOROIDAL NEOVASCULARIZATION USING ANTI-ANG2 X VEGF MULTI-SPECIFIC ANTIBODIES
#5341ANTIBODY AGAINST SARS-COV-2
#5342COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS
#5343PEPTIDE COMPOUNDS AND METHODS OF USE
#5344POLYPEPTIDE COMPOUND AND APPLICATION THEREOF
#5345SELECTIVE MODULATORS OF MUTANT LRRK2 PROTEOLYSIS AND ASSOCIATED METHODS OF USE
#5346SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND METHODS OF USE
#5347N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)benzamide Derivatives
#5348OTHER HETEROAROMATIC COMPOUNDS HAVING ACTIVITY AGAINST RSV
#5349Pyrimidine compound as JAK kinase inhibitor
#5350CRYSTALLINE FORMS, COMPOSITIONS CONTAINING SAME, AND METHODS OF THEIR USE
#5351NOVEL QUINAZOLINONES THAT INHIBIT THE FORMATION OF TAU OLIGOMERS AND THEIR METHOD OF USE
#5352S6K1 protein kinase inhibitors as cancer therapeutics
#5353TRYPTAMINE DERIVATIVES AND THEIR THERAPEUTIC USES
#5354PSYCHOTROPIC AGENTS AND USES THEREOF
#5355MICRONEEDLE DEVICE FOR CONTROL OF THYROID HORMONE LEVELS
#5356METHODS AND SORTILIN BINDING CONJUGATE COMPOUNDS FOR TARGETING CANCER STEM CELLS
#5357A SIRNA DRUG, A PHARMACEUTICAL COMPOSITION, A SIRNA-SMALL MOLECULE DRUG CONJUGATE, AND THE APPLICATION THEREOF
#5358DICHALCOGENIDE PRODRUGS
#5359SYSTEMS AND METHODS FOR EXPRESSING BIOMOLECULES IN A SUBJECT
#5360Composition and methods for MRNA vaccines against novel omicron coronavirus infections
#5361Compositions And Methods Of MAIT Cell Activation
#5362METHOD OF TREATING SCHIZOPHRENIA OR SCHIZOPHRENIFORM DISORDER
#5363COMPOSITIONS AND METHODS FOR CANCER THERAPY
#5364Methods and compositions for the prevention or treatment of Barth Syndrome
#5365ENGINEERED IMMUNE CELL THERAPEUTICS AND METHODS OF USE
#5366COMPOSITIONS AND METHODS FOR TREATING SOLID TUMORS
#5367PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#5368COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
#5369HETEROCYCLIC COMPOUNDS AS PAD INHIBITORS
#5370USE OF SELECTIVE VEGFR2 AND FGFR1 INHIBITORS
#5371VASOPROTECTIVE AND CARDIOPROTECTIVE ANTIDIABETIC THERAPY
#5372Heterocyclic compounds, preparation methods and uses thereof
#5373METHODS AND COMPOSITIONS FOR PREDICTING AND PREVENTING RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA
#5374METHOD OF TREATING ALZHEIMER’S DISEASE
#5375COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDER
#5376Compositions and methods to improve the therapeutic benefit of suboptimally chemical compounds and biological therapies including substituted camptothecins such as irinotecan and topotecan for the treatment of benign and neoplastic hyperproliferative disease conditions, infections, inflammatory and immunological diseases
#5377METHOD OF NORMALIZING THE NEUTROPHIL TO LYMPHOCYTE RATIO IN CANCER PATIENTS WITH A SELECTIVE GLUCOCORTICOID RECEPTOR ANTAGONIST
#5378C-Met Modulator Pharmaceutical Compositions
#5379METHODS OF DIAGNOSING AND TREATING ADHD IN BIOMARKER POSITIVE SUBJECTS
#5380EP300 DEGRADER AND USES THEREOF IN NEUROBLASTOMA
#5381COMBINATION THERAPY USING AZABICYCLO COMPOUND FOR CANCER
#5382COMPOSITIONS AND METHODS FOR TREATMENT OF BLEPHARITIS
#5383Treatment of circadian rhythm disorders
#5384FATTY ACID DERIVATIVES FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS
#5385Methods of treatment of cholestatic diseases
#5386METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA
#5387IRON OXIDE NANOPARTICLES COMPRISING TWO CENTERS OF ACTIVITIES OR FREE RADICAL CAPTURE/PRODUCTION FOR AN ENHANCED ACTIVITY AND COMBINING SPATIAL AND TEMPORAL SEQUENCES OF IRRADIATION USING THE NANOPARTICLES FOR AN IMPROVED TREATMENT OF DISEASES
#5388METHOD OF APPLYING ELECTRICAL IMPULSES FOR THE PURPOSE OF LOADING VARIOUS MOLECULES INTO PLANT-DERIVED NANOVESICLES
#5389POLYMERIC IMPLANTS WITH HIGH DRUG LOADING AND LONG-ACTING DRUG RELEASE AND METHODS OF MAKING THE SAME
#5390ROLLED ORAL THIN FILMS HAVING A HIGH LEVEL OF ACTIVE-INGREDIENT LOADING
#5391LIQUID BIOPSY YIELD ENHANCEMENT
#5392THERAPEUTIC STRATEGIES TO TARGET TUMORS WITH ALTERATIONS IN LKB1 PATHWAY
#5393Oncolytic Virus and Methods of Use
#5394GLYCOFORM SPECIFIC NANOBODIES AND METHODS OF USE
#5395ANTI-KIT ANTIBODIES AND USES THEREOF
#5396LYM-1 AND LYM-2 ANTIBODY COMPOSITIONS AND IMPROVED CAR CONSTRUCTS
#5397PD-L1-SPECIFIC ANTIBODIES AND METHODS OF USING THE SAME
#5398ANTI-IGFBP7 CONSTRUCTS AND USES THEREOF
#5399LILRB1 AND LILRB2-BINDING MOLECULES AND USES THEREFOR
#5400ANTI-CD47 AGENT-BASED OVARIAN CANCER THERAPY